Senior Health link

MMWR

Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants – 24 States, December 2024-April 2025

November 24, 2025 4:00 am Published by Comments Off on Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants – 24 States, December 2024-April 2025

This report describes a multicenter case-control investigation that found nirsevimab was 80% effective at preventing RSV-associated ICU admissions among infants.... View Article


Notes from the Field: Expanding Birthing Hospital Enrollment in the Vaccines for Children Program to Increase Infant Immunization Against Respiratory Syncytial Virus – United States, October 2023-March 2025

November 24, 2025 4:00 am Published by Comments Off on Notes from the Field: Expanding Birthing Hospital Enrollment in the Vaccines for Children Program to Increase Infant Immunization Against Respiratory Syncytial Virus – United States, October 2023-March 2025

Image Learn More


Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness – Eight Southern Hemisphere Countries, March-September 2025

September 29, 2025 6:04 am Published by Comments Off on Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness – Eight Southern Hemisphere Countries, March-September 2025

This report describes flu vaccine effectiveness in the Southern Hemisphere during the 2025 flu season. Learn More


Chat Icon